How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and "tomorrow"

Area of Science:

• Neonatology
• Pediatric Pulmonology
• Critical Care Medicine

Background:

• Bronchopulmonary dysplasia (BPD) is the most prevalent chronic lung disease in neonates.
• It arises from a complex interplay of genetic predisposition, antenatal/postnatal infections, hyperoxia, and mechanical ventilation in immature lungs.
• These factors lead to persistent inflammation, impaired alveolarization, and dysregulated vascularization.

Purpose of the Study:

• To review current management strategies for BPD.
• To explore emerging therapeutic approaches for BPD.
• To identify interventions that may decrease BPD incidence in neonatal intensive care units.

Main Methods:

• Literature review of current BPD management.
• Analysis of recent research on novel BPD therapies.
• Synthesis of evidence for future clinical application.

Main Results:

• Current management focuses on supportive care and minimizing lung injury.
• Emerging strategies target inflammation, alveolar development, and vascular repair.
• Several promising therapies are under investigation.

Conclusions:

• Optimizing current care is crucial.
• Novel therapeutic strategies hold promise for reducing BPD.
• A multi-faceted approach is needed to decrease BPD incidence.